Innovative Technology With Novel
Technology
Based on Ultrapure Chitosan, We Have Created a New Generation of Biomimetic and Regenerative Scaffold
How does it work? Chitin (C8H13O5N)n was isolated and characterized in 1823 by Auguste Odier as a long-chain homopolymer of N-acetyl-d-glucosamine (GlcNAc), (1–4)-linked 2-acetamido-2-deoxy-β-d-glucan. Our technology is based on Chitosan; a nontoxic biopolymer produced by the deacetylation of chitin.
Sound Complicated? Well, a Little, But that’s Where the Experts at Bioxis Come in…
Using advanced techniques, Bioxis has developed a unique technology based on ultrapure chitosan, with outstanding physico-chemical and morphological properties. This makes it possible to:
- Promote cell interactions
- Mimic the extracellular matrix to enhance colonization by autologous cells
- Facilitate tissue regeneration
Pipeline
Bioxis’ Active Research Programs
Transform Doctors’ Ability to Repair Soft Tissue…
Our ongoing R&D efforts provide new formulations and additional indications to address unmet needs of aesthetic dermatology.
